Study eye blood-flow changes in multiple sclerosis
Part of Brain & nervous system, Eyes & vision, Immune system & allergy clinical trials.
This study measures how blood flow in the eye changes in people with relapsing-remitting multiple sclerosis (RRMS) who previously had optic neuritis. The goal is to understand eye/brain blood-flow signals and how they may relate to MS.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Be 18 or older
- Have RRMS diagnosed by a neurologist, not “possible MS” only
- Have had optic neuritis (AON) in one eye at least 1 year ago
- Do not smoke and do not have substance/alcohol misuse
- Have normal eye exam and good eyesight (best-corrected vision at least 0.5 on Snellen)
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial uses brain MRI and eye imaging tests to study research markers in people with multiple sclerosis (MS) and related neurologic conditions. It may help researchers better understand these diseases and how they change over time.
This study checks whether a specific eye-scanning technology gives consistent, repeatable results. It enrolls healthy adults to see if the test works reliably before being used more broadly.
This study compares eye blood-flow/brain-eye communication signals in people with glaucoma (or high eye pressure) versus people with normal eye tests. It may help researchers understand how glaucoma develops and progresses.
This study measures blood flow and oxygen use in the retina (the light-sensing layer at the back of your eye) in adults with type 2 diabetes and in healthy adults. It may help researchers better understand how diabetes affects the eye.
This study uses a special eye scan (OCT-A) and a vision test (perimetry) to see how MS affects the eyes over time. It may help doctors better understand and monitor MS-related eye damage.
This study uses advanced eye scans (OCT and retinal vessel imaging) to look for patterns in the retina that might be different in people with Multiple Sclerosis and other neuroinflammatory diseases. The goal is to find markers that could help doctors better understand and monitor these conditions.
Hear when a new Multiple Sclerosis, Relapsing-Remitting trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.